Metformin may help some people with PCOS lose a modest amount of weight, mainly by improving insulin resistance rather than directly “burning fat” 2, 3. It works best when paired with nutrition, activity, and sleep changes. It is not the strongest weight-loss medication, and it is not recommended for every person with PCOS.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What is the connection between PCOS, insulin resistance, and weight gain?
PCOS — polycystic ovary syndrome, also called polyendocrine metabolic ovarian syndrome in some newer sources — is often linked with insulin resistance, higher androgen levels, irregular ovulation, and weight gain around the abdomen. Diagnostic criteria generally look for ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology after other causes are excluded 1.
Why PCOS can make weight loss harder
Insulin is the hormone that helps move glucose from the blood into cells. In insulin resistance, the body needs more insulin to do the same job. Higher insulin levels can interact with the ovaries and androgen production, which may worsen acne, unwanted hair growth, chronic anovulation, oligomenorrhea, and weight changes in some people with PCOS 1.
This does not mean weight gain is your fault. PCOS weight changes can reflect biology, appetite signals, sleep quality, mental health, activity limits, medications, and genetics. The goal is not blame; it is finding the right plan.
Why weight changes can affect cycles, ovulation, and metabolic risk
For some people with PCOS and overweight or obesity, clinically appropriate weight loss can improve insulin resistance and may improve cycle regularity or ovulation. But response varies, and no medication guarantees cycle normalization, fertility, or a specific weight-loss result 1, 2.
Why PCOS is not just a reproductive condition
PCOS is also linked with prediabetes, type 2 diabetes mellitus, metabolic syndrome, metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnea, infertility, and cardiovascular risk factors 1. That is why good PCOS care often includes glucose testing, lipid testing, blood pressure review, sleep screening, and a medication review.
Does metformin help with weight loss in PCOS?
Metformin can help some people with PCOS lose a small amount of weight, but it is best understood as an insulin-sensitizing medication, not a primary weight-loss drug. Reviews of metformin in PCOS suggest its weight effect is usually modest and works best when combined with lifestyle treatment 2, 3.
What metformin does in the body
Metformin, sold under brand names such as Glucophage, is a biguanide. It lowers hepatic glucose production, improves insulin sensitivity, and can reduce glucose absorption in the gut; those effects are why it is widely used in type 2 diabetes and why clinicians may consider it in PCOS with metabolic risk 4.
What studies and reviews suggest about weight change
The best summary is simple: metformin may help, but it is not dramatic for most people. In PCOS reviews, metformin is more consistently discussed for insulin resistance, glucose risk, and ovulatory or cycle outcomes than for large weight loss 2, 5. Individual results vary.
Why results vary from person to person
Metformin response depends on starting weight, insulin resistance, calorie intake, activity, sleep, gut tolerance, dose prescribed by the clinician, other medications, and pregnancy goals. If nausea or diarrhea lowers food intake early on, that is not the same as healthy fat loss.
What metformin is more likely to help
Metformin is often most relevant when PCOS comes with insulin resistance, impaired glucose tolerance, prediabetes, type 2 diabetes risk, or metabolic syndrome features. It may also be used when cycle irregularity and ovulatory dysfunction are part of the broader metabolic picture, but it is not a universal PCOS treatment 1, 6.
How long does it take to lose weight on metformin with PCOS?
Weight change on metformin is usually judged over several months. If weight changes happen in the first few days, they are more likely to reflect fluid shifts, appetite changes, or stomach side effects than true body-fat change.
Why changes are usually measured over months, not days
PCOS-related weight is driven by long-term energy balance, insulin resistance, sleep, and hormone signals. Metformin’s metabolic effects also build with continued use and tolerability, which is why clinicians usually reassess symptoms, side effects, labs, and weight trend over time rather than after a few doses 2.
Why early side effects are not the same as healthy fat loss
Common metformin side effects include nausea, loose stools, cramping, and a metallic taste. Some people eat less because they feel unwell. That may move the scale, but it is not the goal; persistent side effects deserve a clinician review 4, 6.
When to reassess with a clinician
A clinician may reassess if side effects do not improve, periods become very heavy or stop unexpectedly, pregnancy is possible, blood sugar is high, or weight is changing quickly without a clear reason. They may also check kidney function and vitamin B12 status because metformin safety depends on the full health picture 4, 6.
Can you lose 20 pounds on metformin with PCOS?
A 20-pound goal depends on starting weight, food intake, activity, sleep, medications, and medical conditions. Metformin alone should not be framed as a rapid 20-pound weight-loss plan for PCOS.
Some people may lose that amount over time as part of a broader plan, especially if they also change nutrition, movement, sleep, and other risk factors. But metformin’s average weight effect in PCOS is generally modest, and a goal such as 20 pounds in 2 months may be unrealistic or unsafe for many patients 2, 3.
A safer question for your clinician is: “What rate of weight loss makes sense for my health, labs, menstrual symptoms, and pregnancy plans?” That keeps the plan grounded in your risk profile rather than a fixed number.
Why is metformin not recommended for every person with PCOS?
Metformin is not for everyone with PCOS because PCOS is not one single problem. Some people mainly need cycle control, androgen treatment, fertility care, sleep apnea care, or anti-obesity treatment rather than an insulin-sensitizing medicine.
When metformin may be considered
A clinician may discuss metformin when PCOS overlaps with insulin resistance, prediabetes, impaired glucose tolerance, type 2 diabetes risk, or metabolic syndrome. It may also be considered when lifestyle treatment alone is not enough for metabolic goals 1, 6.
When another treatment may be more appropriate
If the main concern is heavy bleeding, infertility, acne, hirsutism, thyroid symptoms, or high prolactin, another workup or treatment may fit better. PCOS symptoms can overlap with other endocrine conditions, so diagnosis should not be assumed from weight gain or irregular periods alone 1.
Common side effects and safety checks
Metformin can cause gastrointestinal side effects, and longer-term use has been linked with vitamin B12 deficiency risk in some patients. Rare but serious lactic acidosis risk is one reason kidney function and other health factors matter before and during treatment 4, 6.
Why kidney function, pregnancy goals, and other medications matter
Kidney disease, liver disease, heavy alcohol use, pregnancy goals, contrast imaging, and other medications can affect whether metformin is appropriate. If pregnancy is possible or planned, medication choices should be reviewed before conception whenever possible 6, 7.
What else helps PCOS-related weight loss?
Lifestyle treatment remains first-line for most PCOS-related weight concerns. That does not mean “try harder”; it means the strongest starting point is a realistic plan for food, movement, sleep, and metabolic screening.
Nutrition and activity changes with the strongest evidence base
PCOS guidelines and reviews support lifestyle intervention as a core treatment, especially when overweight, obesity, insulin resistance, or metabolic risk is present 1, 2. The best plan is one you can repeat: higher protein and fiber, fewer ultra-processed foods, strength training, walking, and a calorie target if weight loss is a goal.
Sleep, stress, and obstructive sleep apnea screening
Sleep matters because PCOS is associated with obstructive sleep apnea and metabolic risk 1. Loud snoring, daytime sleepiness, morning headaches, or high blood pressure are reasons to ask about sleep apnea screening.
Treating prediabetes, type 2 diabetes, metabolic syndrome, or fatty liver risk
If labs show prediabetes, type 2 diabetes mellitus, abnormal lipids, high liver enzymes, or metabolic dysfunction-associated steatotic liver disease risk, treatment should target those conditions too. PCOS care often improves when the metabolic plan is specific, not just “lose weight” 1.
When anti-obesity medication may be discussed
For patients with obesity, or overweight with weight-related risk factors, a clinician may discuss prescription anti-obesity medication. That decision should be based on BMI, health history, contraindications, pregnancy plans, side effects, access, and patient goals — not PCOS status alone 8, 9.
3-min quiz
Considering prescription weight-management care?
Chia offers online clinician review for eligible weight-management patients, including compounded semaglutide injection and compounded tirzepatide tablets or injection. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
How do metformin and GLP-1 medications compare for PCOS weight concerns?
Metformin and GLP-1 medications work differently. Metformin mainly improves insulin sensitivity and glucose handling, while semaglutide and tirzepatide act on incretin pathways that affect appetite, fullness, insulin secretion, and glucose control 4, 8, 9.
Semaglutide is the active ingredient in Wegovy and Ozempic and is a GLP-1 receptor agonist; compounded semaglutide via 503A pharmacy is a separate compounded prescription formulation. Tirzepatide is the active ingredient in Zepbound and Mounjaro and is a dual GIP/GLP-1 receptor agonist; compounded tirzepatide via 503A pharmacy is a separate compounded prescription formulation. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
| Option | How it may fit PCOS-related weight concerns | Main limits and safety points |
|---|---|---|
| Lifestyle treatment | First-line for most people; targets nutrition, activity, sleep, insulin resistance, and cardiometabolic risk. | Hard to sustain without support; may not be enough alone for obesity, prediabetes, or type 2 diabetes risk. |
| Metformin | May fit people with PCOS plus insulin resistance, impaired glucose tolerance, prediabetes, or type 2 diabetes risk. | Weight loss is usually modest; GI side effects, kidney function, B12 status, and pregnancy plans matter. |
| Semaglutide | May be discussed for eligible weight-management patients with obesity or overweight with risk factors; semaglutide is also being studied in PCOS, including comparison with metformin 10. | Not a PCOS cure; can cause GI side effects and is not appropriate for everyone. Compounded formulations are not FDA-approved. |
| Tirzepatide | May be discussed for eligible weight-management patients with obesity or overweight with risk factors. | Not a PCOS cure; can cause GI side effects and has contraindications and precautions that require clinician review. |
If you want a deeper overview of medication choices, our guides to PCOS medicine for weight loss, metformin for weight loss, and prescriptions for weight loss explain how clinicians compare options.
PCOS-related weight care at Chia: where GLP-1 treatment may fit
Chia does not offer metformin. We do offer clinician-reviewed weight-management care for eligible patients, including semaglutide injection and tirzepatide tablets or injection. These treatments may fit some people with PCOS-related weight concerns, but they are not PCOS diagnosis tools and are not PCOS cures.
At Chia, care starts with a short online health questionnaire. A licensed US provider reviews your health history and prescribes only when clinically appropriate. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Dosing is provider-guided and adjusted over time, including microdosing plans for semaglutide and tirzepatide when clinically appropriate.
| Chia option | Forms Chia offers | Current starting price | Where it may fit |
|---|---|---|---|
| Semaglutide | Injection | Plans currently start at $249/mo | Eligible weight-management patients after licensed-provider review; microdosing plans available when clinically appropriate. |
| Tirzepatide | Tablets or injection | Tablets currently start at $249/mo; injection currently starts at $299/mo | Eligible weight-management patients after licensed-provider review; microdosing plans available when clinically appropriate. |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | Plans currently start at $309/mo | May be considered when a clinician determines the protocol fits the patient’s weight and energy goals. |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | Plans currently start at $329/mo | May be considered when a clinician determines the protocol fits the patient’s weight and body-composition goals. |
Some patients compare broader online care models before starting. Our guides to GLP-1 medication online and GLP-1 weight-loss programs explain safety checks, prescription requirements, and how to avoid no-prescription medication sellers.
If you use an AI agent for prescription-delivery workflows, Chia can also be reached through DoctorMCP at mcp.chia.health. The same rule applies: any prescription requires a licensed-provider evaluation and is never guaranteed.
Which option fits which person?
The right next step depends on what is driving the weight concern. PCOS can overlap with insulin resistance, thyroid disease, sleep apnea, depression, medication effects, or pregnancy-related goals, so the safest plan starts with evaluation.
| If this sounds like you | A sensible next step | Why |
|---|---|---|
| Irregular periods, acne or hair growth, and new weight gain without a PCOS diagnosis | See a clinician for diagnosis and labs before choosing medication. | PCOS symptoms overlap with other endocrine conditions. |
| PCOS plus prediabetes, impaired glucose tolerance, or strong insulin resistance signs | Ask whether metformin, lifestyle treatment, or another metabolic plan fits. | Metformin is most relevant when metabolic risk is present. |
| PCOS plus obesity, or overweight with weight-related risk factors | Ask whether anti-obesity medication, including a GLP-1 option, is appropriate. | Eligibility depends on BMI, risks, contraindications, and pregnancy plans. |
| Trying to conceive now or soon | Review all medications with an OB-GYN, reproductive endocrinologist, or prescribing clinician. | Pregnancy goals can change medication choice and timing. |
| Severe snoring, daytime sleepiness, or high blood pressure | Ask about obstructive sleep apnea screening. | Sleep apnea is more common in PCOS and can affect weight and metabolic health. |
What should you ask your clinician if you have PCOS and want to lose weight?
Bring specific questions to the visit. The goal is to separate PCOS-related weight gain from other causes and match treatment to your risk profile.
- Do I meet diagnostic criteria for PCOS, or could thyroid disease, high prolactin, adrenal disease, pregnancy, or another condition explain my symptoms?
- Should I be screened for prediabetes, type 2 diabetes, lipids, liver health, blood pressure, obstructive sleep apnea, or thyroid disease?
- Is metformin appropriate for my insulin resistance or glucose risk?
- Do I meet criteria to discuss a GLP-1 or GIP/GLP-1 medication for weight management?
- How should pregnancy plans affect medication choice and timing?
- What side effects should make me stop and call you?
- How will we track progress besides the scale, such as A1C, waist size, cycles, energy, sleep, or blood pressure?
When should you get medical help now?
Get urgent help for severe abdominal pain, fainting, chest pain, shortness of breath, signs of severe dehydration, or very heavy bleeding. These symptoms should not be managed as routine PCOS weight concerns.
You should also contact a clinician promptly if you might be pregnant, periods stop unexpectedly, weight changes quickly without trying, blood sugar is very high, vomiting prevents fluids, or medication side effects are persistent.
3-min quiz
Start with a clinician-reviewed weight-care plan
If PCOS-related weight concerns are part of your health picture, Chia can evaluate whether weight-management treatment is clinically appropriate. Options may include semaglutide injection, tirzepatide tablets or injection, Weight + Energy, or Weight + Muscle, depending on your health history and goals. A prescription is never guaranteed.
FAQ
They are different medications used for different reasons. Semaglutide is an incretin-based medication that may be considered for eligible weight-management patients, while metformin is mainly an insulin-sensitizing medication 4, 8. Compounded semaglutide is not FDA-approved, and outcomes are not FDA-evaluated for compounded formulations.
Tirzepatide may be discussed for weight management in eligible patients with obesity or overweight with risk factors, including some people who also have PCOS 9. It is not a cure for PCOS, and pregnancy plans, contraindications, side effects, and clinician judgment matter.
Some patients are prescribed metformin with an incretin-based medication, but that decision requires a clinician review of glucose risk, side effects, kidney function, other medications, and pregnancy plans. Do not combine prescription medications without medical guidance.
No. Chia does not offer metformin. Chia offers clinician-reviewed compounded semaglutide injection and compounded tirzepatide tablets or injection for eligible weight-management patients after an online medical evaluation.
References
- 1.Rosenfield RL, Ehrmann DA. Polyendocrine Metabolic Ovarian Syndrome. StatPearls. 2026.
- 2.Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction. 2023.
- 3.Metformin use in women with polycystic ovary syndrome (PCOS). 2025.
- 4.Role of Metformin in Polycystic Ovary Syndrome (PCOS). 2023.
- 5.Revisiting Metformin in the Management of Polycystic Ovary Syndrome. 2025.
- 6.U.S. Food and Drug Administration. Metformin Hydrochloride Tablets Prescribing Information. 2022.
- 7.Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine. 2008.
- 8.U.S. Food and Drug Administration. Wegovy (semaglutide) Injection Prescribing Information. 2024.
- 9.U.S. Food and Drug Administration. Zepbound (tirzepatide) Injection Prescribing Information. 2024.
- 10.ClinicalTrials.gov. Semaglutide vs Metformin in Polycystic Ovary Syndrome. NCT05646199. 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



